|
1D2B
THE MMP-INHIBITORY, N-TERMINAL DOMAIN OF HUMAN TISSUE INHIBITOR OF METALLOPROTEINASES-1 (N-TIMP-1), SOLUTION NMR, 29 STRUCTURES
Deposited 1999-09-22
|
Different construct
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
24–149(126 aa)
Fragment:NTR domain, residues 24-149
|
Not recorded
|
No recorded non-water small molecule
|
SOLUTION NMR
NMR measurement conditions
pH 6;293 K;Ionic strength (raw mmCIF value) 0.171;Pressure AMBIENT
NMR sample composition
0.5 MM N-TIMP-1 U-15N
NMR sample composition
0.9 MM N-TIMP-1 U-15N,13C
NMR sample composition
0.7 MM N-TIMP-1 U-15N,13C
NMR sample composition
0.4 MM N-TIMP-1 16% 13C
NMR sample composition
0.4 MM N-TIMP-1 U-15N,13C
|
Resolution not provided
|
|
1OO9
Orientation in Solution of MMP-3 Catalytic Domain and N-TIMP-1 from Residual Dipolar Couplings
Deposited 2003-03-03
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain B
24–149(126 aa)
Fragment:N-TERMINAL DOMAIN
|
Not recorded
|
No recorded non-water small molecule
|
SOLUTION NMR
NMR measurement conditions
pH 6.6;310 K;Ionic strength (raw mmCIF value) 20mM Tris-d11; 100 mM NaCl; 15 mM CaCl2; 3uM ZnCl2; 1mM Sodium Azide;Pressure ambient
NMR measurement conditions
pH 6.7;307 K;Ionic strength (raw mmCIF value) 20mM Tris-d11; 125mM NaCl; 15 mM CaCl2; 50uM ZnCl2;1mM Sodium Azide;Pressure ambient
NMR sample composition
0.8mM MMP-3 U-15N, 13C; 0.8mM N-TIMP-1;
20mM Tris-d11; 100 mM NaCl; 15 mM CaCl2; 3uM ZnCl2;
1mM Sodium Azide; 93% H2O, 7% D2O | 93% H2O/7% D2O
NMR sample composition
0.5mM MMP-3 U-2H, 15N; 0.5mM N-TIMP-1;
20mM Tris-d11; 100 mM NaCl; 15 mM CaCl2; 3uM ZnCl2;
1mM Sodium Azide; 93% H2O, 7% D2O | 93% H2O/7% D2O
NMR sample composition
0.66mM N-TIMP-1 U-15N, 13C; 0.66mM MMP-3(E202Q);
20mM Tris-d11; 125mM NaCl; 15 mM CaCl2; 50uM ZnCl2;
1mM Sodium Azide; 93% H2O; 7% D2O | 93% H2O/7% D2O
NMR sample composition
0.3mM 98% 2H/15N N-TIMP-1; 0.3mM MMP-3 (E202Q);
20mM Tris-d11; 125mM NaCl; 15 mM CaCl2; 50uM ZnCl2;
1mM Sodium Azide; 93% H2O; 7% D2O | 93% H2O/7% D2O
NMR sample composition
0.3mM 98% 2H/15N N-TIMP-1; 0.3mM (15N-IV, 15N, 13C-L)MMP-3(E202Q);
20mM Tris-d11; 125mM NaCl; 15 mM CaCl2; 50uM ZnCl2;
1mM Sodium Azide; 93% H2O; 7% D2O | 93% H2O/7% D2O
NMR sample composition
0.3mM 98% 2H/15N N-TIMP-1; 0.3mM (15N-IV, 15N, 13C-L)MMP-3(E202Q);
20mM Tris-d11; 125mM NaCl; 15 mM CaCl2; 50uM ZnCl2;
1mM Sodium Azide; 93% H2O; 7% D2O
5% PEG(C12E6)/1-hexanol | 93% H2O; 7% D2O
5% PEG(C12E6)/1-hexanol
|
Resolution not provided
|
|
1UEA
MMP-3/TIMP-1 COMPLEX
Deposited 1997-06-06
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain B
24–207(184 aa)
|
Not recorded
|
ZN ZINC ION × 2
CA CALCIUM ION × 3
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 2.80 Å
|
|
1UEA
MMP-3/TIMP-1 COMPLEX
Deposited 1997-06-06
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain D
24–207(184 aa)
|
Not recorded
|
ZN ZINC ION × 2
CA CALCIUM ION × 3
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 2.80 Å
|
|
2J0T
Crystal Structure of the Catalytic Domain of MMP-1 in Complex with the Inhibitory Domain of TIMP-1
Deposited 2006-08-04
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain D
24–149(126 aa)
Fragment:N-TERMINAL INHIBITORY DOMAIN, RESIDUES 24-149
|
Not recorded
|
ZN ZINC ION × 2
CA CALCIUM ION × 3
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 7.5;10% PEG 8000, 8% ETHYLENE GLYCOL, 0.1M HEPES (PH 7.5).
|
Resolution 2.54 Å
R-free 0.275
|
|
2J0T
Crystal Structure of the Catalytic Domain of MMP-1 in Complex with the Inhibitory Domain of TIMP-1
Deposited 2006-08-04
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain E
24–149(126 aa)
Fragment:N-TERMINAL INHIBITORY DOMAIN, RESIDUES 24-149
|
Not recorded
|
ZN ZINC ION × 2
CA CALCIUM ION × 3
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 7.5;10% PEG 8000, 8% ETHYLENE GLYCOL, 0.1M HEPES (PH 7.5).
|
Resolution 2.54 Å
R-free 0.275
|
|
2J0T
Crystal Structure of the Catalytic Domain of MMP-1 in Complex with the Inhibitory Domain of TIMP-1
Deposited 2006-08-04
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain F
24–149(126 aa)
Fragment:N-TERMINAL INHIBITORY DOMAIN, RESIDUES 24-149
|
Not recorded
|
ZN ZINC ION × 2
CA CALCIUM ION × 3
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 7.5;10% PEG 8000, 8% ETHYLENE GLYCOL, 0.1M HEPES (PH 7.5).
|
Resolution 2.54 Å
R-free 0.275
|
|
3MA2
Complex membrane type-1 matrix metalloproteinase (MT1-MMP) with tissue inhibitor of metalloproteinase-1 (TIMP-1)
Deposited 2010-03-23
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain C
24–148(125 aa)
Fragment:Residues 24-148
|
Mutation:V27A,P29V,T121L
|
CA CALCIUM ION × 2
ZN ZINC ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 5.5;292 K;100 mM Bis-Tris pH 5.5, 20% PEG 3350, VAPOR DIFFUSION, HANGING DROP, temperature 292K
|
Resolution 2.05 Å
R-free 0.247
|
|
3MA2
Complex membrane type-1 matrix metalloproteinase (MT1-MMP) with tissue inhibitor of metalloproteinase-1 (TIMP-1)
Deposited 2010-03-23
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain B
24–148(125 aa)
Fragment:Residues 24-148
|
Mutation:V27A,P29V,T121L
|
CA CALCIUM ION × 2
ZN ZINC ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 5.5;292 K;100 mM Bis-Tris pH 5.5, 20% PEG 3350, VAPOR DIFFUSION, HANGING DROP, temperature 292K
|
Resolution 2.05 Å
R-free 0.247
|
|
3V96
Complex of matrix metalloproteinase-10 catalytic domain (MMP-10cd) with tissue inhibitor of metalloproteinases-1 (TIMP-1)
Deposited 2011-12-23
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
24–207(184 aa)
Fragment:unp residues 24-207
|
Mutation:N30A
|
PO4 PHOSPHATE ION × 2
ZN ZINC ION × 2
CA CALCIUM ION × 3
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 6.5;298 K;0.1 M sodium dihydrogen phosphate solution, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K
|
Resolution 1.90 Å
R-free 0.266
|
|
6MAV
Complex of tissue inhibitor of metalloproteinase-1 (TIMP-1) mutant L34G with matrix metalloproteinase-3 catalytic domain (MMP-3cd)
Deposited 2018-08-28
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain B
24–207(184 aa)
|
Mutation:L34G
|
CA CALCIUM ION × 3
ZN ZINC ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 5.5;298 K;0.1 M Ammonium Acetate 0.1 M Bis-Tris: HCl, pH 5.5, 17 % (w/v) PEG 10,000
|
Resolution 2.37 Å
R-free 0.298
|
|
6N9D
Complex of tissue inhibitor of metalloproteinases-1 (TIMP-1) mutant (L34G/L133P/L151C/G154A) with matrix metalloproteinase-3 catalytic domain (MMP-3cd)
Deposited 2018-12-03
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain B
24–207(184 aa)
|
Not recorded
|
CA CALCIUM ION × 3
ZN ZINC ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;298 K;0.2 M Sodium Acetate, 0.1 M Sodium Cacodylate: HCl, pH 6.5 18 % (w/v) PEG 8000
|
Resolution 2.67 Å
R-free 0.258
|
|
7S7L
Complex of tissue inhibitor of metalloproteinases-1 (TIMP-1) mutant (L34G/M66S/E67Y/L133N/S155L) with matrix metalloproteinase-3 catalytic domain (MMP-3cd)
Deposited 2021-09-16
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain B
24–207(184 aa)
|
Mutation:L34G, M66S, E67Y, L133N, S155L
|
CA CALCIUM ION × 3
ZN ZINC ION × 2
CL CHLORIDE ION × 1
TRS 2-AMINO-2-HYDROXYMETHYL-PROPANE-1,3-DIOL × 1
SO4 SULFATE ION × 1
GOL GLYCEROL × 1
ACT ACETATE ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.5;310 K;0.2M ammonium sulfate, 0.1M Bis-Tris pH 6.5, 25% w/v PEG 3350
Anatrace-Microlytic Top96 #65
|
Resolution 2.34 Å
R-free 0.239
|
|
7S7M
Complex of tissue inhibitor of metalloproteinases-1 (TIMP-1) mutant (L34G/M66D/T98G/P131S/Q153N) with matrix metalloproteinase-3 catalytic domain (MMP-3cd)
Deposited 2021-09-16
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain B
24–207(184 aa)
|
Mutation:L34G, M66D, T98G, P131S, Q153N
|
CA CALCIUM ION × 3
ZN ZINC ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 5.5;310 K;0.1 M ammonium acetate, 0.1 M Bis-Tris-HCl, pH 5.5, 17% w/v PEG10000
|
Resolution 3.00 Å
R-free 0.248
|
|
9SOQ
Tissue inhibitor of Metalloproteinase 1 (TIMP-1)
Deposited 2025-09-15
|
Different construct
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
24–207(184 aa)
|
Not recorded
|
FLC CITRATE ANION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 5.6;293.15 K;0.2 Ammonium Sulphate,
0.1 M tri-sodium citrate,
25% PEG4000
|
Resolution 2.30 Å
R-free 0.262
|
|
9SOQ
Tissue inhibitor of Metalloproteinase 1 (TIMP-1)
Deposited 2025-09-15
|
Different construct
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain B
24–207(184 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 5.6;293.15 K;0.2 Ammonium Sulphate,
0.1 M tri-sodium citrate,
25% PEG4000
|
Resolution 2.30 Å
R-free 0.262
|
|
9SOS
Tissue Inhibitor of Matrix Metalloproteinase-1 (TIMP-1)
Deposited 2025-09-15
|
Different construct
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
24–207(184 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 8.4;293.15 K;0.2 M Lithium Citrate tribasic tetrahydrate,
20% PEG3350
|
Resolution 2.00 Å
R-free 0.255
|